Retired
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you for your message
FY2021 revenues were $4.7M, a 219% increase vs FY2020,
4Q21 revenues were $1.3M, an 8% increase versus $1.2M in 3Q21,
1Q22 ‘expected’ $1.45M to $1.6M would be a 15% to 25% increase vs 4Q21
By the way, a $10 revenue in FY22 would represent an increase of 113% over FY21 ($4,687M)
As you say,: 'let's just wait to see the SALES numbers' ...
Summary
Despite Covid-related delays,
Management expects to top $10 million in annual revenue
There are several imminent developments that are potential catalysts for share price appreciation.
Else is conducting clinical trials to validate product benefits for targeted markets and for regulatory approval for infant formula, which is likely to become Else's lead product sometime next year.
She obviously doesn't understand what managing a publicly help startup should imply ...
COVID is irrelevant in our case
Focus and priorities are on research, 'development', 'clinical trials', ..
Projected sales of $10M hardly can justify the current MC of $125M, even assuming no increase in O/S. By the way, based on her forecast of a Q1 revenue (I took the $1,6 million) ... assuming a revenue growth of 10% Q to Q thereafter ... means that our FY 2022 total revenue would only be $7,5 millions. For getting a $9,9M revenue, a growht of revenues Q to Q would have to be 30%. I have a serious doubt that to be, unless major management decisions are made.
Unfortunately (I stand to be corrected) I believe her board and main advisors are (no doubt) reat scientific people but I also believe that Marketeers of experience are missing in her top executive team. Our CEO seams to believe that having good products is sufficient (Many found out how wrong such a belief can be) and that seems to be all she does focus on.
I for one, even if I believe in the products (actual and future) will reduce my position by 50% profiting from the next significant pps spike. I shall buyback in, whenever I feel someone has its main focus on 'market development' or when our market cap is based on a more justified multiplier.
So sorry ... GLTA
Looks like many gave up ($0,07) ...
If CEO has a plan and a little respect for the shareholders he will issue some kind of corporate update ... unless he has no serious plan and cannot care less about us.
What is wrong with this outfit. They lied all the way or what ???
So many products (very often the best of its class) failed because people tought that 'THE PRODUCT' would do it. Let's hope our management realise it soon otherwise, best case, someone will buy them for cheap unless they just let it go away as did Betamax (just an example).
Rool o thumb is that for any $ you invest to create a product, you should spend the same number of $ in marketing it. By the way marketing is an art made of multiple basic functions from Planning, pricing, to communicating,to selling to measuring and understanding results to adapting the whole process.
When I was still in the business (22 years ago) I consulted with small inventors of great products who had spent all their money creating the product, before they knew of that rule. Some just fade away and others soldout to large corporation that made a lot of money out of these products.
Some quote from experts
The sky’s the limit, or so the saying goes. And if you’re a talented entrepreneur with a great new product, what can possibly go wrong? Apparently quite a lot: According to Harvard Business School professor Clayton Christensen, there are over 30,000 new products introduced every year, and 95% fail. Ouch. biggest problem we’ve encountered is lack of preparation: Companies are so focused on designing and manufacturing new products that they postpone the hard work of getting ready to market them until too late in the game.
According to a leading market research firm, about 75% of consumer packaged goods and retail products fail to earn even $7.5 million during their first year.
Rool o thumb was
Rool o thumb was
I find interesting to read all these comments, knowing nothing about where the company stands but only having documented (filed) financials going back more than 6 months (filings of Q3 2021). Someone is even crazy enough to post based on FACTS based on up to 5 years old informations ???
Let's face it, rightfully or not, for goods reasons or not, Leon only give away very basic and legally required info.
Any shareholders therefore has to either believe that there is a potential interesting gain to have in some future (???) or one believes that this is a total failure n the making (even a scam according to some) and I assume him to be smart enough to not be shareholders anymore.
For whoever is still a shareholder, he must understand that:
- GRST is a risky pinky offering great gain potential,
- GRST is traded on a dangerous market, manipulated by some,
- GRST has reduced debts and did grow revenues,
- GRST is managed by a successful executive who doesn’t try to BS people,
- GRST’S CEO is having significant initial success at reviving a company that was in a deep coma only months ago.
Bottom line:
- If our CEO fails, we will have to write off our bet/investment (hopefully not having bet the rent to start with)
- If our CEO succeeds, we are in for quite an interesting financial gain.
Do your onw DD and Good luck
They effectively 'gotta find a way'. My concern is that how management seems to think that 'having the product' will bring success automatically.
The reason I agreed with Lazerking40 definition is that he was right writing: “get the word out, create brand recognition, push for customer acquisition, and provide a product that results in customer loyalty/retention. The product speaks for itself, but does no good if no one can hear about it“.
Marketing is not a science (scientific must understand that) IT'S AN ART that Marketers must be skilled at.
A marketers team should be led by:
- Product managers (PM), responsible for understanding user needs, setting the product roadmap, working with R&D experts to deliver features attractive to consumers. They monitor trends and develop pricing strategies and advertising campaigns. They should plan, influence and control messages. They must be held accountable for the product's success or failure.
- Product Marketing managers (PMM) responsible to communicate the product’s value to the market. They are the voice of the customers and are mandated to understand consumer's needs user’s reactions to our products. Using that knowledge they must develop and execute strategies promoting our brands and products, maximizing profits for the company.
Our management must understand that success will come from:
- Scientifics creating a great products (Else has it)
- An appropiate manufacturing capability (large investments required)
- A 'Marketeers team' creating a BALANCED GROWTH i.e. both Revenues and profits for the company (large expenses required)
Right now, I do not think management understand that or just can afford it all by themselves and that is why, finding an appropriate partner (along the line of what I hypothetically outlined earlier) seems to me a REQUIREMENT.
Contrary to the belief of our CEO (her statement of last November) Time (5 years or more) is not an allied but our worst ennemy.
Let's hope She figure that out and get someone investigate opportunities that must be available considering the products we have and will have.
GLTA
Better have it one week later than having it with an unfnished story. It seem that the management is building on its experience of the lats years (growing revenues) and planning a future aimed at balanced growth. I like it
The Very Good Food Company Reschedules its 4th Quarter Conference Call to Thursday April 14, 2022 - 04/06/2022 4:07:00 PM
VANCOUVER, BC, April 6, 2022 /PRNewswire/ - The Very Good Food Company Inc. (NASDAQ: VGFC) (TSXV: VERY.V) (FSE: OSI) ("VERY GOOD" or the "Company"), a leading plant-based food technology company, is moving its fourth quarter earnings call that was scheduled for today to Thursday April 14, 2022 at 1:30 pm PT at which time, the call will also include a business and management update.
In light of the management changes that were announced on Monday; the creation of the Executive Committee; and the implementation of cost improvement measures, the Company needs additional time to complete our analysis and prepare communication to be able to address the questions of shareholders and other stakeholders. We thank you for your patience.
Better have it one week later than having it with an unfnished story. It seem that the management is building on its experience of the lats years (growing revenues) and planning a future aimed at balanced growth. I like it
The Very Good Food Company Reschedules its 4th Quarter Conference Call to Thursday April 14, 2022 - 04/06/2022 4:07:00 PM
VANCOUVER, BC, April 6, 2022 /PRNewswire/ - The Very Good Food Company Inc. (NASDAQ: VGFC) (TSXV: VERY.V) (FSE: OSI) ("VERY GOOD" or the "Company"), a leading plant-based food technology company, is moving its fourth quarter earnings call that was scheduled for today to Thursday April 14, 2022 at 1:30 pm PT at which time, the call will also include a business and management update.
In light of the management changes that were announced on Monday; the creation of the Executive Committee; and the implementation of cost improvement measures, the Company needs additional time to complete our analysis and prepare communication to be able to address the questions of shareholders and other stakeholders. We thank you for your patience.
Better have it one week later than having it with an unfnished story. It seem that the management is building on its experience of the lats years (growing revenues) and planning a future aimed at balanced growth. I like it
The Very Good Food Company Reschedules its 4th Quarter Conference Call to Thursday April 14, 2022 - 04/06/2022 4:07:00 PM
VANCOUVER, BC, April 6, 2022 /PRNewswire/ - The Very Good Food Company Inc. (NASDAQ: VGFC) (TSXV: VERY.V) (FSE: OSI) ("VERY GOOD" or the "Company"), a leading plant-based food technology company, is moving its fourth quarter earnings call that was scheduled for today to Thursday April 14, 2022 at 1:30 pm PT at which time, the call will also include a business and management update.
In light of the management changes that were announced on Monday; the creation of the Executive Committee; and the implementation of cost improvement measures, the Company needs additional time to complete our analysis and prepare communication to be able to address the questions of shareholders and other stakeholders. We thank you for your patience.
On FEb.21 I outline a hypothetical scenario giving our CEO the ossibility to do what she likes and is good at (R & D) and the shareholders an opportunity to succeed marketing wise. I did it following a news relative to ABBOTT and outline an idea kind of answering your question.
Your outline of what has to be done is right on (Gotta get the word out, create brand recognition, push for customer acquisition, and provide a product that results in customer loyalty/retention. The product speaks for itself, but does no good if no one can hear it).
I also bet they (she) will figure it out sooner than later and hope they are not dreamers more or less in touch with reality.
Nowadayus more than ever before, windows of opportuniy do close quite fast. I know she did mentionned 5 years last November but believe me, 5 years is an eternity in this world of plant food we somewhat are included in. Unless revenues do grow a lot and I mean A LOT more than what we see now,losses will cripple the company till someone buy it out for much less than we all would believe possible.
My unit cost is below USD $1,00 but the way it goes, this may be a lot considering our current market cap.
GLTA
Looks like the market doesn't believe they do ???
Unbelieveable the number of posts on this message board that are insignificant. Not even worth reading them anymore.
Less than half an hour after the market opening, the pps is at US$ 0,9x. I wonder is our CEO aware of it and still believing she is successful. Does she think that a Q1 Fy2022 showing sales of $ 1,5M will please the market.
What will it take for her to figure out she has a great product but no marketing worth mentionning and no manufacturing facility worth talking about.
Unless she figures out she has a shortcoming and needs help, she may endup as part of the business failures of companies that failed with the best products.
Do I have to say I agree? Our CEO has no clue relative to the Marketing/selling ART ... even being obviously a great R & D expert.
I wonder, assuming she doesn't read this board (LOL), Does any of her adviser help her figuring out that lining up boxes on shelves is not Marketing ... obviously.
Honestly, !% is marketing (adding two additional products) the remaining of the PR (not really a NR) talks about the product once again.
All those aware of Else do know of the product but the level of market awareness hasn't change.
Ho yes, the PR proudly add: 'following the successful launch and performance of Else Toddler Nutrition' ???
Big Y, One of the Largest Supermarket Chains in the Northeast, to Sell Else Kids Nutrition Products - 04/06/2022 7:00:00 AM
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), the Plant-Based baby, toddler, and children nutrition company, today announced that following the successful launch and performance of Else Toddler Nutrition, retailer Big Y will be adding two additional products – Else Plant-Based Kids Shakes, in chocolate and vanilla flavors, at all locations. The products are expected to hit the shelf in Q2 and extend the ' 'brand's shelf presence and offerings of its Clean Label certified, whole Plant-Based nutrition into the kids' segment.
Made from whole food, clean ingredients, including organic almonds, buckwheat, and tapioca, which account for over 90 percent of the ingredients, Else Complete Nutrition Shakes for Kids are packed with nutrients, free from dairy, soy, gluten, and contain 50 percent less sugar than other options available in the market. The products are specially designed to help support the growth and development of children.
Since launching its Plant-Based Complete Nutrition for Toddlers, which won the Good Housekeeping Parenting Award for 2021, the brand has received powerful testimonials and reviews from moms. Else Toddler Nutrition was also awarded "Best dairy alternative" at World Plant-Based Expo in December of 2021. It was also a finalist at the Nexty Awards at Expo West 2022.
Madam Yitzhak, I think the market is sending you a message. By the way current MC of $130,000,000 represents a multiplier of 20+. That cannot be sustained considering your recent revenue forecast.
I hope that some of your directors and advisors understading financials will help you figure out what you do wrong (And believe me I definitely do not mean on the scientific side of the equation).
Qtrly Rev: $19,500,000 ??? Where does that come from?
I really do not understand at all what you see in these charts but not generally being a trader (I’m INVESTING), I always have 1 or 2 little pinky stock(s) I can play with to fill boring waiting time (managing investments is as fun as looking at the grass grow). The fun part comes in particular from following and participating in the message boards.
Started playing with this (toy) recently at $0,00221/sh then played half my shares, selling up and buying down a couple of time already. I’m now at a pps of $0,00182 and on the sell side once again to get down to an avg. pps of $0,0015. My plan is to own some (few) shares at no cost and let them go till it either dies or grow seriously. No risk of loss and potential interesting gain.
I admit not to know that much about this stock (BNOW) but I look for PR’s or NR’s to learn more ???
Whatever you are here for … GLTA!
That means a MC of more or less $120,000,000.
Assuming a revenue of $1,300,000 in Q1 and a + or - 10% growth Q to Q that would mean a total revenue in 2022 of $6,000,000:
Q1: 1,300,000
Q2: 1,450,000
Q3: 1,500,000
Q4: 1,750,000
A $0,03 pps would mean a multiplier of about 20 that I cannot see ???
I however did not include any specific development Leon could realise to grow the business faster.
I would personally be happy with a pps of about $0,015 but still this would mean a multiplier of about 10.
I hope Leon will soon come up with some kind of growth strategy other than strickly more of the same+.
I'm the one who unlocked the situation at 4 apr. 2022 13:56:40 ET throwing in some left over money in my cash account (500,000 shares at $0,0008).
Whatever will happen, for the moment at least, I trust our CEO and do not believe he is in that only to screw small investors to make a few thousands $$$. I believe he works hard as ressussitating a business that was in a deep come and that he has a plan he works on. Time will tell but a makket cap of more or less $40,000,000 is not that unreasoneable to believe in (assuming 4,000,000,000 O/S) that means a pps of $0.01 or a multiplier of less than 7).
Thereafter, what Leon works on on a STRATEGIC basis, will make that a great stock to own.
Ho my God... You could have provoked our crazy expert. I bet he will soon post one of his usual 'copy/paste' forecasting disaster.
takeover bid (taking good care and keeping current management happy) would be the best thing that could happen.
Other are great also but do not address my ongoing (marketing) concern.
I'm back to my 20,000 shares base that I intend to keep, believing that our executives do understand what their shortcmings are. I would not be surprised if some negociations were going on behind the scene ... but who knows?
Total revenues (Total Loss)
31 mar. 2021 : 2,643 (15,029)
30 jun. 2021 : 2,781 (12,501)
30 sep. 2021 : 2,536 (13,700)
31 dec. 2021 : 4,299 (13,331)
That’s why the recent decisions were justified and appropriate. The company:
- When thru a first phase, INVESTING in the establishment of its products in the market
- Starts a second phase aimed at creating profits
This entrance in a new management philosophy also explain why some executives must be replaced or do decide to go.
I very much like what is being done at this time in the building of the company.
What are key objectives set:
- 'optimizing our operations towards a path to profitable growth'
- 'transitions from a focus on top line growth, to a focus on achieving sustainable, profitable growth'
Obviously this tough but smart decision was'nt probably aggreed to by all and aimig at 'BALANCED GROWTH' was obviously the smart move to make.
I doubled my position.
The Very Good Food Company Announces Management Changes and Formation of an Executive Committee - 04/04/2022 5:00:00 AM
VANCOUVER, BC, April 4, 2022 /CNW/ - The Very Good Food Company Inc. (NASDAQ: VGFC) (TSXV: VERY.V) (FSE: OSI) ("VERY GOOD" or the "Company"), a leading plant-based food technology company, today announced that Mitchell Scott's employment as Chief Executive Officer has been terminated effective immediately. The Company also announced that James Davison has resigned as Chief Research & Development Officer and as a member of the board of directors as of April 1, 2022.
The Very Good Food Company Inc. (CNW Group/The Very Good Food Company Inc.)
In lieu of immediately filling the role of Chief Executive Officer, VERY GOOD has temporarily created an Executive Committee consisting of senior executives from within the Company. The Executive Committee structure will be used by the organization to review and approve key organizational, financial, operational and strategic decisions for the Company, by drawing upon the collective knowledge, experience, business acumen and skills of the senior management team.
A search for a new Chief Executive Officer is being initiated by the Nomination Committee with the help of a leading Vancouver based recruiting agency.
"VERY GOOD is at an important juncture, and we are taking decisive steps. Our focus is to continue to build on our brand and reputation and grow our market share in the plant-based meat segment while optimizing our operations towards a path to profitable growth", stated Ana Silva, President of VERY GOOD, who is also a member of the Executive committee.
Ms. Silva continued: "As announced on March 16, 2022, VERY GOOD is implementing cost improvement measures as it transitions from a focus on top line growth, to a focus on achieving sustainable, profitable growth. These measures include:
Improve the economics of the e-commerce business. The digital marketing costs to acquire new customers through our e-commerce business have increased over the last year such that it impedes the profitability of this channel. The Company is shifting the focus from digital marketing campaigns that are aimed at acquiring new customers to our existing subscribers and those customers that are driven to our website because of our existing brand awareness and equity.
Right-size the organization through a workforce reduction. A workforce reduction will occur across multiple business operations which will result in a sizable reduction in total annual salaries. The Company is also evaluating different options for consolidating its production facilities to improve efficiencies.
"As we go forward, we will continue to execute against a strong set of strategies that will help us to further drive our top line growth by expanding our distribution points and improving our customer and consumer marketing model. And while we expect some volatility in the next couple of quarters as we set up cost improvement initiatives and work to streamline our operations, our long-term growth thesis remains intact as we continue to lead and innovate within the plant-based food industry", said Ana Silva, President.
The Q4 and Fiscal Year End 2021 Conference Call has been scheduled for Wednesday, April 6, 2022 to discuss the business outlook. This conference call includes a live Q&A session hosted by the members of the Executive Committee.
DITTO ... ' Still holding betting they figure the marketing out.'
I intend to wait before buying back recently sold shares. I have a problem with a MC of $145,000,000 for a compny generating $5,000,000 in 2021 (multiplier of 29).
I do believe (still) in the company and hope that our CEO has business / marketing type advisers around her to explain to her that having a great product is only 50% of the story.
Unfortunately, my experience shows that technical/scientists type people are very tough to convince that the other ingredient (Marketing/Sales) is a must to have a winning team. 'Marketing only' as well as 'enginneering/scientific' only are 2 roads to failure.
I personally saw to many entrepreneurs failing because they thougt they did not need the other skilled discipline on their team (most of the time was scientific people not respecting marketing ones).
Timing is of the essence.
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25 (b).
The Company intends to file its Annual Report on Form 10-K on or before the fifteenth calendar day following the prescribed due date.
I think the market is sending a message to Madam Hamutal Yitzhak
Hamutal Yitzhak, CEO of Else Nutrition commented: “We are happy with the progress we made in 2021…
PPS in the last year:
Dec. 2020 $5,00 +
Feb. 2021 $4,47
Aug. 2021 $2,80
Nov. 2021 $2,00
Mar. 2021 $1,20
Revenues last year:
Déc. 31 2020 : $ 598,000
Mar. 31 2021: $ 1,135,000
June 30 2021: $ 1,114,000
Sept. 30 2021: $1,170,000
Dec. 31 2021: $1,300,000
Mar. 31 2022: $1,500,000 (As per recent PR)
She obviously refer to the R&D side of the business …
Retired, I gave already. I'm sure some qualified experts are available but I doubt our management does think they need help. As the saying goes: 'You can bring someone to the river but you cannot force him to drink the water'
By the way, within our direction we have people comming from ABBOTT (I believe ???). That's why I posted the following earlier (Post # 4530):
BEIJING, Feb 21 (Reuters) - China Customs has warned consumers from buying and eating some infant and baby products of Abbott … ‘BEIJING, Feb 21 - China Customs has warned consumers from buying and eating some infant and baby products of Abbott’.
With the disastrous image falling out of the recent news, not only ABBOTT ‘infant and baby products’ be ‘marketing wise’ destroyed for a very long time but, any such product marketed under the name of ABBOTT will meet a lot of public resistance.
Assuming ABBOTT very seriously want to rapidly (relatively) recuperate from this blow and assuming they see ELSE as an alternative, a scenario ABBOTT could envisage would be:
1 - Create an ABBOTT laboratories baby food ‘new subsidiary’ named (example): Natural Infant and Baby Food (NIBF), financing it with issuing 17,500,000, new shares representing a dilution of less than 1% considering current ABBOTT 1,768,000,000 O/S.
2 - Make NIBF a 2 divisions company:
- One division with an R&D and product development mission (mostly the current Else operation) and
- another division mandated to market the products developed by the first division.
3 - Make current executives of Else manage the first division
- Assign some current marketing executives from ABBOTT to run the other division.
With a financial base of more than $ 1,750,000,000 (17,500,000 ABBOT shares at $100+) the NIBF would
- help ABBOTT get back into its crippled markets and
- make our current Else executive team keep doing what they are good at, still profiting from what they created and will create in the future.
Remember,
- currently ABBOTT market cap is at US $206,000,000,000 BABYF -
- market cap of NIBF would be $1,750,000,000 and
- BABYF’s is just over US $100,000,000.
Following such an Hypothetical scenario NIBF (an ABBOTT wholy own subsidiary could:
- easily offer US $9,00/BABYF shares (less than $ 1,000,000,000
worth of shares)
- have $ 750,000,000 left to grow its business worldwide.
3 questions:
- How bad is ABBOTT hurt by recent news?
- How aggressive would ABBOTT want to be to get back (indirectly)
into their crippled market?
- How much does current management want to remain totally
independent?
It’s nice to dream about what the world may be 5 years down the road but 5 years is a very long way out and the current seen market opportunity may not wait for our management forever.
Again I hope our management also belive in the old say:
A Bird in the Hand is Worth Two in the Bush
'In Q4 2021 Else concluded a successful preclinical safety study'.
'The study results will be presented in ... meetings focused on pediatric nutrition and will be published in scientific peer-reviewed journals'.
Else is in close communication with the FDA ... to receive their guidance throughout the process of Else’s infant formula development'.
'Else also worked on preparations for the three clinical studies ... we plan to continue our research activity ... as well as provide scientific support for our products including preparations for additional clinical studies'.
That is a great definition of HALF THE MANDATE our management should commit to.
Looking forward to learn about the other half ...
During my career I consulted many small companies havig spent a lot developping products and they very often were under shock when I told them that 'for every $$$ you spent developping your product, you must spend at least that many to market it'. Many did not have enough financial ressources to do it.
Fortunately, Else have access to such ressources but $$$ do not replace skilled marketing professionnals. Let's hope that message comes accross to our management.
Post# 4573
Total quaterly revenues
Déc. 31 2020 : $ 598,000
March 31 2021: $ 1,135,000
June 30 2021: $ 1,114,000
Sept. 30 2021: $1,170,000
Dec. 31 2021: ??? We now know:4Q21 revenues were $1.3M
Concernig. To be proud of a growth from FY2020 results is to say the least an easy person to satisfy.
The company was founded in 2019, Revenues in 2020 were only $1,5M (no issue with that) but 2021 results are nothing to be proud of (no significant growth Q t Q).
The good news:
The products are great (I almost wrote revolutionay),
Cash balance was $25.5M
The Company had no Loans liability
The bad news:
Failed marketing results (even first quarter revenues look bad at only + or - $1,5M. The partnering with multiple large successful distributing organisations has been promoted for more than 1 year (Walmart and Kroger online platforms, . Amazon in the US and EU aimed at UK, Germany, France, Italy, Spain, the Netherlands, and Sweden, ... still the company expect (even seem to be satisfied) with projected revenues of $1,5M 1n Q1 2022.
Why I stay (at somewhat a lower # of shares - 20,000) I respect our CEO and its team relative to their R&D skills.
Why I am concerned ... Many outstanding revolutionary products never became successful because management did not really understand what is required to be successful in the market (Japaneeses did figure that out at the end of the last century (I saw it first hand).
What I look for is for our management to finally understand that BEFORE IT'S TO LATE.